MedPath

Short Duration Versus Fourteen Days Antibiotic in Common Bile Duct Cholangitis

Not Applicable
Completed
Conditions
Acute Cholangitis
Common Bile Duct Calculi
Interventions
Other: Standard treatment of antibiotic
Other: Short duration of antibiotic
Registration Number
NCT03422042
Lead Sponsor
Prince of Songkla University
Brief Summary

Common bile duct stone cholangitis is a potentially fatal condition, characterized by an obstruction and bacterial infection of biliary system. The principles of management are appropriate biliary drainage and systemic antibiotics. There has been limited data about appropriate time of antibiotics in patient with successful endoscopic drainage.

Detailed Description

The aim is comparing the efficacy and safety between short duration and standard fourteen days antibiotic treatment in patients with acute common bile duct stone (CBDS) cholangitis after successful endoscopic biliary drainage as regards recurrence rate of acute cholangitis, complete stone clearance rate, morbidity and mortality associated acute cholangitis, and complications related ERCP procedure.

The study will be divided patients with acute CBDS cholangitis with complete stone clearance into 2 groups, group (A) will be received intravenous antibiotic until the temperature is less than 37.8 c for 72 hours and group (B) will be received intravenous antibiotic for 7 days, followed by oral antibiotic for 7 days, regardless of the body temperature.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • age ≥ 18 years old
  • diagnosis of acute mild to moderate severity of ascending common bile duct stone cholangitis
  • endoscopic retrograde cholangiopancreatography (ERCP) with biliary drainage within 72 hours after admission
Exclusion Criteria
  • pregnant woman
  • the cause of obstruction other than common bile duct stone
  • severe co-morbid diseases such as cardiovascular/pulmonary/kidney disease
  • active concomitant infections of other organs
  • history of allergy to cephalosporin group

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard treatment of antibioticStandard treatment of antibioticgroup B: will received intravenous antibiotic for 7 days, and followed by oral antibiotic for 7 days, regardless of body temperature
Short duration of antibioticShort duration of antibioticgroup A: will received intravenous antibiotic until the temperature is less than 37.8 c for 72 hours, then antibiotic is discontinued
Primary Outcome Measures
NameTimeMethod
The recurrence rate of cholangitis8 weeks

The number of patients who has recurrence of fever after complete treatment without other sources identified

Secondary Outcome Measures
NameTimeMethod
Mortality rate4 weeks

The number of patient with death

The rate of adequacy of drainage24 hours

The number of patient with cholangiography at the end of the procedure showed no fill defect in the bile duct.

Complication rate4 weeks

The number of patients who developed complications related procedure included pancreatitis, bleeding, perforation, cholangitis as defined and graded according to the consensus guideline and sedation related complications.

Trial Locations

Locations (1)

NKC Institue of Gastroenterology and Hepatology, Prince of Songkla University

🇹🇭

Hatyai, Songkla, Thailand

© Copyright 2025. All Rights Reserved by MedPath